Alain Bankier

CEO, Nexien BioPharma, Inc.

Alain Bankier is Managing Partner of VSTechVentures, a partnership that provides capital, legal, tech and business advisory to companies in the cannabis industry, including extraction, brands, technology and research. He is also Chief Strategy Officer for Intiva BioPharma, Inc. an R&D company focused on cannabinoid-based pharmaceutical formulations for medical conditions and disorders.

Alain is the co-founder of the New York Angels, one of the leading early stage investment groups in the US, where he focuses on legal cannabis, technology and food/tech industries. He is also a member of ArcView. In the cannabis industry, Alain has invested in variety of (public and private) legal cannabis companies, including: cultivation, processing, dispensaries, R&D and technology, edibles and other ancillary businesses.

Until 2014, Alain was a shareholder and Co-President/CEO of The Manischewitz Company. Prior to his career in the food industry, Alain was Head of Corporate Finance/Mergers and Acquisitions North Americas, at BNP Paribas until 2001.

Alain has a BS from the Wharton School and a BA from the University of Pennsylvania. He also has an MBA from NYU Stern and from HEC Paris.